Way above my expectations, very happy.
The annc does mention 'increased marketing expenditure' however this has been well flagged. The prospectus earlier this year stated under section 1.3, the first listed purpose of the CR was 'increasing marketing of the Company’s products and services to fast track growth' which they were allocating $2.4M.
Here are the advertising and marketing costs of the last few quarters:
Q1 FY15 $289K 2/2/15
Q2 FY15 $838K 2/2/15 !!!
Q3 FY15 $252K 30/4/15
Q4 FY15 $211K 31/7/15
I would suggest the Q3 and Q4 values were low to conserve cash but now that they have capital again, the value will likely match the Q2 value or be higher. However, regardless of what the figure may be, I think we can all happily say growth has indeed been fast tracked!
- Forums
- ASX - By Stock
- ODA
- Smartrans
Smartrans, page-22
Featured News
Add ODA (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $22.83M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $807 | 5.981K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3740 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 10131 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3740 | 0.135 |
1 | 54367 | 0.130 |
1 | 25000 | 0.125 |
3 | 93000 | 0.120 |
1 | 100000 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 10131 | 1 |
0.160 | 61533 | 2 |
0.165 | 5807 | 1 |
0.180 | 26234 | 1 |
0.220 | 16153 | 1 |
Last trade - 12.55pm 15/11/2024 (20 minute delay) ? |
Featured News
ODA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online